IN Dexmedetomidine for Procedural Sedation in Pediatric Closed Reductions for Distal Forearm Fractures
Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the sedative, and analgesic effects of
intranasal (IN) Dexmedetomidine (DEX) in children presenting to a Pediatric Emergency
Department (PED) who undergo conscious sedation for reduction of closed distal forearm
fractures when compared to those receiving intravenous (IV) Ketamine. The secondary objective
is to compare each sedation technique for safety and procedural outcomes.
Phase:
Early Phase 1
Details
Lead Sponsor:
Phoenix Children's Hospital
Treatments:
Analgesics Dexmedetomidine Hypnotics and Sedatives Ketamine